Skip to content

Analgesic effects of multimodal analgesia for patients undergoing radical thyroidectomy

Analgesic effects of multimodal analgesia for patients undergoing radical thyroidectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800020290
Enrollment
Unknown
Registered
2018-12-22
Start date
2019-02-01
Completion date
Unknown
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid cancer

Interventions

1:multimodal analgesia
2:tramadol

Sponsors

Beijing Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) patients scheduled for radical thyroidectomy under general anesthesia; 2) ASA I~II; 3) aged 18 and 75 years old; 4) BMI<32kg/m2

Exclusion criteria

Exclusion criteria: 1) history of chronic pain or chronic use of analgesics; 2) patients who had received NSAIDs, opioids, or other analgesics in the 24 h before surgery; 3) patients with a history of allergic reaction to NSAIDs; 4) patients with any contraindications for flurbiprofen axetil, such as coagulation disorders, gastrointestinal ulcer, severe hypertension, severe cardiovascular or cerebrovascular disease, or renal dysfunction; 5) patients who were pregnant or lactating; 6) patients unable to comprehend the concept of the numeric rating scale (NRS; 0, no pain; 10, worst pain imaginable); 7) patients who underwent lateral neck dissection during surgery; 8) patients who refused to participate in the study.

Design outcomes

Primary

MeasureTime frame
NRS score;

Secondary

MeasureTime frame
postoperative nausea and vomiting;hemodynamic response;

Countries

China

Contacts

Public ContactLi Xiaoxi

Beijing Cancer Hospital

lixiaoxi8754@163.com+86 13426242782

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 20, 2026